Guizhou Xinbang Pharmaceutical Co., Ltd. cancelled the acquisition of 80% stake in Guizhou Tianyou Chinese Western Medicine Co., Ltd.
January 02, 2019
Share
Guizhou Xinbang Pharmaceutical Co., Ltd. (SZSE:002390) agreed to acquire 80% stake in Guizhou Tianyou Chinese Western Medicine Co., Ltd for CNY 3.6 million on January 2, 2018. The transaction does not need to be submitted for review in the directorate meeting.
Guizhou Xinbang Pharmaceutical Co., Ltd. (SZSE:002390) cancelled the acquisition of 80% stake in Guizhou Tianyou Chinese Western Medicine Co., Ltd on January 2, 2019.
GUIZHOU XINBANG PHARMACEUTICAL Co., LTD is a China-based company, principally engaged in the research and development, manufacture and distribution of medical products. The Company operates its businesses through three segments. The Pharmaceutical Manufacturing segment is engaged in the manufacture and distribution of Chinese patent medicines, such as Ginkgo Leaves Tablets. The Pharmaceutical Distribution segment includes rapid wholesale business and medicine retail business. The Medical Services segment is engaged in the provision of medical services. It operates its businesses primarily in domestic markets.